Paul Black Biography and Net Worth

CEO of Veradigm

Paul Black currently serves as board member and chief executive officer (CEO) of Allscripts. As CEO, Paul guides company direction to fulfill its global commitment to build open, connected communities of health.

Before joining Allscripts in 2012, Paul spent more than 13 years with Cerner Corporation in various executive positions, retiring as Cerner’s chief operating officer in 2007. During his tenure with Cerner, he helped build the company into a market leader in healthcare information technology with more than $1.5 billion in annual revenue. Paul also spent 12 years with IBM Corporation in a variety of leadership positions in sales, product marketing and professional services.

Paul has served on several private company and nonprofit boards of directors for companies in healthcare information technology, healthcare services and consumer Internet marketing. He is currently immediate past chairman and an officer of Truman Medical Centers, a 400-bed safety net academic hospital in Kansas City, Missouri. Paul holds a Bachelor of Science degree from Iowa State University and a Master of Business Administration from the University of Iowa.

What is Paul Black's net worth?: The estimated net worth of Paul Black is at least $5.47 million as of June 10th, 2022. Mr. Black owns 1,254,631 shares of Veradigm stock worth more than $5,470,191 as of April 1st. This net worth estimate does not reflect any other investments that Mr. Black may own. Learn More about Paul Black's net worth.
How do I contact Paul Black?: The corporate mailing address for Mr. Black and other Veradigm executives is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. Veradigm can also be reached via phone at (800) 334-8534 and via email at stephen.shulstein@allscripts.com. Learn More on Paul Black's contact information.
Has Paul Black been buying or selling shares of Veradigm?: Paul Black has not been actively trading shares of Veradigm during the past quarter. Most recently, Paul Black sold 60,000 shares of the business's stock in a transaction on Friday, June 10th. The shares were sold at an average price of $16.58, for a transaction totalling $994,800.00. Following the completion of the sale, the director now directly owns 1,254,631 shares of the company's stock, valued at $20,801,781.98. Learn More on Paul Black's trading history.
Who are Veradigm's active insiders?: Veradigm's insider roster includes Elizabeth Altman (Director), Paul Black (CEO), Greg Garrison (Director), Lisa Khorey (Insider), Michael Klayko (Director), and Richard Poulton (CFO). Learn More on Veradigm's active insiders.

Paul Black Insider Trading History at Veradigm

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/10/2022	Sell	60,000	$16.58	$994,800.00	1,254,631
6/6/2022	Sell	65,450	$17.30	$1,132,285.00	1,389,631
6/3/2022	Sell	75,000	$17.33	$1,299,750.00	1,455,081
5/17/2022	Sell	50,000	$18.18	$909,000.00	1,529,649
3/10/2022	Sell	60,000	$21.87	$1,312,200.00
12/10/2021	Sell	60,000	$17.68	$1,060,800.00
6/14/2021	Sell	120,000	$17.66	$2,119,200.00
3/15/2021	Sell	60,000	$15.72	$943,200.00
12/14/2020	Sell	60,000	$14.03	$841,800.00
10/14/2020	Sell	30,000	$11.04	$331,200.00
3/5/2020	Buy	33,783	$7.22	$243,913.26
12/12/2018	Buy	24,765	$10.10	$250,126.50
9/14/2017	Sell	15,000	$13.52	$202,800.00
9/15/2016	Sell	15,000	$13.00	$195,000.00	1,177,009
6/13/2016	Sell	15,000	$13.04	$195,600.00	1,197,329
3/30/2016	Sell	15,000	$13.31	$199,650.00	1,224,939
12/12/2014	Buy	6,500	$11.51	$74,815.00
11/11/2014	Buy	22,180	$11.26	$249,746.80
5/15/2013	Buy	7,120	$14.02	$99,822.40
3/12/2013	Buy	23,625	$12.69	$299,801.25

See Full Table

Paul Black Buying and Selling Activity at Veradigm

Veradigm Company Overview

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Today's Range

Now: $4.36

$4.05

$4.60

50 Day Range

MA: $5.48

$4.05

$9.00

2 Week Range

Now: $4.36

$4.00

$11.80

Volume

63,302 shs

Average Volume

480,193 shs

Market Capitalization

$469.31 million

P/E Ratio

N/A

Dividend Yield